TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
LBRX

LB Pharmaceuticals Inc

Healthcare · Biotechnology

42.50$ +0.8% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

LB Pharmaceuticals Inc (LBRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -35 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow LBRX
Line item 2022 2023 2024 2025
-2.7 -12 -53 -35
0.0 0.0 0.1 0.3
0.4 0.3 3.2 4.2
0.1 -1.3 3.3 -14
0.0 0.0 0.8 0.1
0.1 -28 23 -40
25 0.7 0.0
23 34 38 303
20 -6.4 8.5 227
-2.7 -12 -54 -35

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?